510 Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: Results From a Phase 1 Study of BemdaneprocelViviane Tabar, Antoine Lampron, Andrés M. Lozano et al.|Neurosurgery|2024Cited by 3